Dr. Robert E. Gerszten is Chief of Cardiovascular Medicine at the Cardiovascular Institute, Professor of Medicine at Harvard Medical School and a Senior Associate Member of the Broad Institute. His research focuses on the nexus of cardiac and metabolic diseases. This translational research program is a national leader in the use of metabolomics and proteomic technologies -- and the integration of this information with human genetics -- for the discovery of new biomarkers and pathways contributing to atherogenesis and its complications. The Gerszten team has identified novel biomarkers that single out individuals destined to develop diabetes and heart disease more than a decade before disease onset, with the goal of determining which of these patients might benefit from clinical interventions. Dr. Gerszten's research is funded by the National Institutes of Health and the American Heart Association. He is an active clinician in the Coronary Care Unit.
Dr. Peter Zimetbaum is a Professor of Medicine at Harvard Medical School and Associate Chief and Director of Clinical Cardiology at BIDMC. He joined BIDMC as an electrophysiologist in 1997. IN addition to his clinical practice, he directs the ECG and Arrhythmia Core Laboratory at the Harvard Clinical Research Institute. Dr. Zimetbaum sees arrhythmia patients at BIDMC and Beth Israel Deaconess Hospital-Milton. His research interests include new drug therapies for arrhythmias as well as health services research and cardiovascular outcomes. He authored the well received textbook, Practical Clinical Electrophysiology.
Dr. Elad Anter is Director of the Electrophysiology Laboratory and an Assistant Professor of Medicine at Harvard Medical School and joined the Harvard-Thorndike Electrophysiology Institute at BIDMC in 2011. He is Director of the Experimental Electrophysiology Research Laboratory and the Associate Director of the clinical Electrophysiology laboratory. Dr. Anter’s main clinical and research focus is the study of arrhythmia mechanisms and the development of novel ablation technologies to improve patient outcomes. He and his collaborators have encouraged the general cardiology and electrophysiology fellows at BIDMC to participate in this cutting edge research.
Dr. Evan Appelbaum serves as Assistant Professor of Medicine at Harvard Medical School and Co-director of the CMR Core Lab at PERFUSE. Dr. Appelbaum is a member of the Noninvasive Cardiac Imaging and Testing section. With a particular interest in cardiovascular magnetic resonance (CMR), his research interests include coronary artery imaging and perfusion assessment using CMR, as well as ventricular remodeling following myocardial infarction. At the CMR Core Lab, Dr. Appelbaum has directed numerous national and international multicenter trials employing CMR.
Dr. Aarti H. Asnani is an attending physician in the Cardio-Oncology Program and a researcher in this field. She joined BIDMC in 2017. Her goal is to define the molecular mechanisms responsible for chemotherapy-induced heart toxicity, a major contributor to morbidity and mortality in the growing population of cancer survivors. Her research interests include the molecular pathways contributing to heart failure induced by a commonly used chemotherapy, doxorubicin.
Dr. Alfred E. Buxton is Professor of Medicine at Harvard Medical School. He serves as Director of the ECG Laboratory and the Clinical Cardiac Electrophysiology Fellowship Program. He has authored or co-authored over 300 publications. He was Principal Investigator of the NIH-funded Multicenter Study of Non-Sustained Ventricular Tachycardia (MUSTT). His current research is focused on methods to predict risk of sudden cardiac death, appropriate role of implantable defibrillators for prevention of sudden cardiac death and mechanisms of ventricular tachycardia.
Dr. James D. Chang , Assistant Professor of Medicine at Harvard Medical School and a member of the Advanced Heart Failure Center program. He is involved in research activities pertaining to early detection and prevention of cancer therapeutics-associated cardiotoxicity and to the role of implantable hemodynamic monitoring devices in the management of advanced heart failure. In addition to his work in advanced heart failure, he is an active member of the echocardiography laboratory.
Dr. Donald Cutlip is an interventional cardiologist and Vice Chair for Network Management and Development in the Department of Medicine. He is Professor of Medicine at Harvard Medical School and a Senior Investigator at the Harvard Clinical Research Institute (HRCI). His research interests include the study of clinical outcomes after percutaneous coronary intervention with special interest in patients with diabetes and stent thrombosis.
Dr. Loryn S. Feinberg is the director of the Women’s Cardiovascular Health Program at Beth Israel Deaconess Medical Center. She specializes in non-invasive cardiology. She joined the cardiology staff at Beth Israel Medical Center in 2006. She is an active member of the Boston board of the American Heart Association. Dr. Feinberg’s clinical areas of interest include women and heart disease, pregnancy and cardiovascular disease and cardio-oncology.
Dr. Airley E. Fish is an Instructor of Medicine at Harvard Medical school and joined the Division of Cardiovascular Division at the BIDMC in 2010. She holds a Master’s in Public Health from John Hopkins University School of Public Health. Her clinical interests include coronary artery disease, valvular heart disease, preventive cardiology and cardiovascular diseases in women.
Dr. Michael C. Gavin is Medical Director of the Cardiac Direct Access Unit and an Instructor of Medicine at Harvard Medical School. Dr. Gavin sees patients into his general cardiology clinic with a focus on valvular heart disease, coronary artery disease and preventive cardiology. He reads stress and rest transthoracic echocardiograms and performs transesophageal echocardiograms. He attends in the Coronary Care Unit and on the Zoll inpatient cardiology service.
Dr. Eli Gelfand is an Assistant Professor of Medicine at Harvard Medical School and Director of Ambulatory Cardiology and the Russian Cardiovascular Clinic at BIDMC where he is responsible for cardiovascular outpatient operations. He is also active in developing the clinical applications of new and rapidly evolving diagnostic imaging modalities, such as three-dimensional (3D) and intracardiac echocardiography (ICE) and cardiovascular magnetic resonance (CMR) imaging with particular focus on imaging support of minimally-invasive therapies for valvular and congenital cardiac disease.
Dr. Ernest Gervino is an Associate Professor of Medicine at Harvard Medical School and has been a member of the Cardiovascular Division since 1981. He is the Director of Clinical Physiology Laboratory at BIDMC and serves as the Director of Exercise Testing Core Lab at the Harvard Clinical Research Institute for both national and international research trials. His research interests include the effects of exercise training on management of patients, diet and behavior modification on the reduction of risk for a second cardiac event.
Dr. C. Michael Gibson is a Professor of Medicine at Harvard Medical School and an interventional cardiologist, cardiovascular researcher and educator who pioneered our understanding of the “open artery hypothesis” as well our understanding of the importance of restoring flow downstream in the capillary bed in the “open microvasculature hypothesis”. He has led his own Academic Research Organization (PERFUSE) for over 20 years, and his work has been presented in over 1000 manuscripts, abstracts, trial summaries, textbooks and textbook chapters. He is Founder and Chairman of the Board of the non-profit WikiDoc foundation, the world’s largest open source textbook of medicine.
Dr. Ary Goldberger , Professor of Medicine at Harvard Medical School, is Director of the Margret and H.A. Rey Institute for Nonlinear Dynamics in Physiology and Medicine and Program Director of the NIH/NCRR Research Resource for Complex Signals (www.physionet.org.). Dr. Goldberger and his colleagues have pioneered the application of fractals to physiology and methods to quantify the breakdown of fractal scaling as they pertain to aging and disease.
Dr. E. Wilson Grandin specializes in advanced heart failure. He is site director of the joint BIDMC-Tufts Medical Center Advanced Fellowship in Heart Failure and Cardiac Transplantation.
Dr. Charles Haffajee is an Associate Professor of Medicine at Harvard Medical School and Director of Device Trials and Cardiac Electrophysiology Network Development. His primary interests are in pacing, defibrillation, congestive heart failure and atrial fibrillation.
Dr. Thomas Hauser is an Assistant Professor of Medicine at Harvard Medical School and Director of Nuclear Cardiology Medicine. His primary research interest is in the clinical application of advanced methods of cardiovascular imaging with particular focus on nuclear cardiology and cardiac MR.
Dr. Kalon Ho is an Assistant Professor of Medicine and the Director of Quality Assurance for BIDMC’s Division of Cardiovascular Medicine. He leads BIDMC’s efforts to monitor the outcomes of cardiovascular care and to improve the quality of that care. He is active in the leadership of the National Cardiovascular Data Registry and the Society for Cardiovascular Angiography and Interventions. His research interests include methodological issues in the design, management and analyses of clinical trials; cost-effectiveness of cardiac interventions; and assessment of outcomes of cardiovascular procedures (including use of large-scale, multicenter databases).
Dr. Peter M. Kang is an Associate Professor of Medicine at Harvard Medical School and Director of the Cardiac Physiology Core. He is a physician-scientist and his laboratory is interested in developing novel therapies for various cardiovascular diseases. His lab is developing novel nanoparticle-based systems that are activated by hydrogen peroxide, to be used in cardiovascular therapeutics and bio-imaging application. In addition, his laboratory is currently investigating the molecular mechanism of cardiac dysfunction associated with vitamin D deficiency and examining the potential role of vitamin D therapy in the treatment of heart failure.
Dr. Joseph P. Kannam is an Assistant Professor of Medicine at Harvard Medical School and director for the Cardiovascular Fellowship Program at Beth Israel Deaconess Medical Center. He is Chief of the Division of Cardiology at Beth Israel Deaconess Hospital-Needham (BID-Needham) and oversees the hospital’s comprehensive community-based cardiology program. He is the immediate past president of the Board of Directors of the Boston Chapter of the American Heart Association. He makes annual trips to Haiti with the organization Hearts Around the World to train local physicians in cardiovascular care.
Dr. Robb Kociol is Associate Director of Advanced Heart Failure and is Director of the Ventricular Assist Device Program. He is trained in advanced heart failure and transplant cardiology. In addition to his clinical duties at BIDMC, he attends on the inpatient cardiac transplant/VAD service at Tufts Medical Center. His current clinical focus is on building the BIDMC heart failure service and spearheading the new bridge to transplant and destination therapy LVAD program. His research interests include quality of care and outcomes among acute HF patients and HF pharmaceutical and device-related clinical trials.
Dr. Maria Irene Kontaridis is an Assistant Professor of Medicine at Harvard Medical School and the Director of the Cardiovascular Research Program at Beth Israel Deaconess Medical Center. Dr. Kontaridis’ research focuses on the fundamental mechanisms underlying both congenital heart disease and end-stage heart failure, and the processes that lead to abnormal development, aberrant signaling and disease onset. She is Chairman of the Research Safety Committee at BIDMC.
Dr. Daniel Kramer is an Assistant Professor of Medicine at Harvard Medical School and joined the cardiac electrophysiology section in 2012. He is the Associate Director of Pacemaker and ICD Service. Dr. Kramer’s research focuses on understanding and improving outcomes of patients with cardiac devices as well as policy analyses of medical device regulation. Dr. Kramer is currently supported by a NIH/NIA Paul Beeson Career Development award as well as funding from the Harvard Catalyst Clinical and Translational Science Center.
Dr. Roger J. Laham is an Associate Professor of Medicine at Harvard Medical School and Co-Director of the Peripheral Vascular Disease Program. Dr. Laham is investigating novel Angiogenesis and Myogenesis strategies including stem cell and myotissue transplantations, Novel imaging modalities including Multidetector CT (320) for coronary artery disease detection and PET/CT for vulnerable plaque imaging. In addition, he is developing and studying several Cardiovascular Devices including percutaneous valves, left atrial exclusion for atrial fibrillation, and myocardial restraint for congestive heart failure.
Dr. David Leeman is an Assistant Professor of Medicine at Harvard Medical School and member of the Interventional Section of the CVI. He has a primary interest in interventional cardiovascular medicine, including angioplasty, stenting, atherectomy, intracoronary ultrasound and angioscopy. He is a coinvestigator in several multicenter trials involving new interventional devices. Dr. Leeman interests also include cholesterol management and research on the regression of coronary artery disease with cholesterol-lowering agents.
Dr. Warren J. Manning is Professor of Medicine and Professor of Radiology at Harvard Medical School and the Section Chief of Noninvasive Cardiac Imaging and Testing where he also serves as Co-director of the Cardiac MR Center and Director of the Echocardiography Laboratory. A former president of the Society for Cardiovascular Magnetic Resonance, his ongoing research interests include cardiovascular applications of magnetic resonance (coronary MRI, valvular heart disease, subclinical atherosclerosis, atrial fibrosis in atrial fibrillation and pericarditis), utilization of echocardiography for prognosis in valvular heart disease and appropriateness of echocardiographic referrals.
Dr. Murray A. Mittleman is an Associate Professor of Medicine at Harvard Medical School and serves as Chair of the Master of Public Health program at the Harvard School of Public Health. Director of Cardiovascular Epidemiology at the Institute for Prevention of Cardiovascular Disease at BIDMC, his applied research is in the area of environmental and behavioral determinants of the onset of acute cardiovascular events, including myocardial infarction, arrhythmias, stroke and congestive heart failure decompensation.
Dr. Reza Nezafat is an Associate Professor of Medicine at Harvard Medical School and serves as the Scientific Director of the Cardiac MR Center. Dr. Nezafat completed his training at Johns Hopkins School of Medicine and National Institute of Health in Biomedical Engineering prior to joining Harvard Medical School. Dr. Nezafat’s research is to develop and apply new non-invasive methods in magnetic resonance imaging to guide therapy in cardiovascular disease.
Dr. Panos Papageorgiou is an Assistant Professor of Medicine at Harvard Medical School. He is a staff electrophysiologist of the Harvard-Thorndike Institute of Electrophysiology. Dr. Papageorgiou’s basic research has included the exploration of the role of the myocardial chloride/bicarbonate exchanger in atrial myocytes, and complex heart rhythm analysis in transgenic mice. His clinical research has focused on atrial anisotropy and atrial pacing for atrial fibrillation prevention.
Dr. Duane S. Pinto is Associate Professor of Medicine, Director of the Cardiac Catheterization Laboratory and Associate Chief of the Interventional Cardiology section . He performs complex coronary and peripheral vascular intervention. He maintains a general cardiology outpatient practice and his research interests include cost effectiveness evaluation of anticoagulation strategies for acute coronary syndromes as well as the development of approaches improving outcomes after myocardial infarction.
Dr. Pablo Quintero Pinzon is an Instructor of Medicine at Harvard Medical School. Dr. Quintero Pinzon completed his fellowship in clinical cardiology at BIDMC and advanced heart failure and transplant at Tufts Medical Center in Boston. Originally from Colombia, he is also part of the Cardiovascular Latino Clinic that delivers culturally sensitive care for Spanish-speaking patients with cardiovascular disease. Dr. Quintero Pinzon sees patients at BIDMC and at BIDMC-Chelsea. His research interest include heart failure/ventricular remodeling and is currently creating a BIDMC/HF biorepository in order to help bridge the gap between basic research and the clinic.
Dr. Jeffrey Popma is a Professor of Medicine at Harvard Medical School. He is Director of Interventional Clinical Cardiology and of the BIDMC Angiographic Core Laboratory for numerous multicenter device studies. Over the past 15 years, he has led clinical trials investigating a broad array of new technologies, including bare metal stents, drug eluting stents, distal protection devices, total occlusion devices, carotid and peripheral revascularization procedures and transcatheter aortic valve and mitral valve therapies.
Dr. Carl Rasmussen is a staff cardiologist at BIDMC and an Instructor of Medicine at Harvard Medical School. His clinical expertise is in the diagnosis and management of rhythm disturbances, utilizing both invasive and noninvasive methods.
Dr. Anne Riley is an Instructor of Medicine at Harvard Medical School and joined the Cardiovascular Division at BIDMC and BID-Needham in 2011. She is a clinical cardiologist who sees general cardiology patients and performs non-invasive cardiac testing at BID-Needham. She attends on the inpatient cardiology service and the cardiology consult service at BIDMC.
Dr. Marwa Sabe is Associate Director of Advanced Heart Failure and Director of the Left Ventricular Assist Device (LVAD) program. She works with patients with temporary and permanent mechanical support devices and heart transplantations at BIDMC and she spends part of each year working at Tufts Medical Center with advanced heart failure patients who have had placement of LVADs and transplants.
Dr. Jeffrey E. Saffitz is Chairman of the Department of Pathology at BIDMC and Mallinckrodt Professor of Pathology at Harvard Medical School. Dr. Saffitz has a longstanding interest in electrical coupling via gap junctions in cardiac myocytes. He has characterized the roles of the individual cardiac connexins in impulse propagation and defined mechanisms by which remodeling of gap junctions in the diseased heart contributes to the pathogenesis of sudden death. His current work is focused on the role of gap junction remodeling in sudden death in arrhythmogenic right ventricular cardiomyopathy.
Dr. Samuel Shubrooks is Associate Professor of Medicine at Harvard Medical School and a member of the interventional cardiology section. Dr. Shubrooks' clinical and research interests include interventional cardiology and aortic and mitral valvuloplasty.
Dr. Alexei Shvilkin is a Clinical Assistant Professor of Medicine at Harvard Medical School He completed residencies at Jacobi Medical Center in Medicine and at BIDMC in in Cardiology and a fellowship at BIDMC in Cardiac Electrophysiology. Dr. Shvilkin is an electrophysiologist at both BIDMC and South Shore Hospital.
Dr. Connie Tsao is Instructor of Medicine at Harvard Medical School. She is a non-invasive cardiologist specializing in clinical cardiovascular imaging (echocardiography, cardiovascular magnetic resonance) and an investigator at the Framingham Heart Study. Her research interests are in noninvasive assessment of cardiovascular structure and function, and the epidemiology of subclinical CVD, cardiac remodeling, vascular stiffness and heart failure.
Dr. Richard Verrier is an Associate Professor of Medicine at Harvard Medical School and Director of the Integrative Cardiac Electrophysiology Laboratory. His research focuses on neural control of heart rhythm with particular reference to the problem of sudden cardiac death. He and his colleagues have demonstrated that T-wave alternans (TWA) magnitude provides a noninvasive index of vulnerability to lethal cardiac arrhythmias and have generated FDA-cleared means to perform TWA testing during routine exercise and ambulatory ECG monitoring.
Dr. Jonathan W. Waks joined the Harvard-Thorndike Electrophysiology Institute at BIDMC after completing his Internal Medicine residency at Brigham and Women's Hospital and fellowships in Cardiovascular Disease and Clinical Cardiac Electrophysiology at BIDMC. He is an Instructor in Medicine at Harvard Medical School. Dr. Waks' main research interests involve use of novel electrocardiographic and vectorcadiographic methods of assessing risk for ventricular arrhythmias and sudden cardiac death. He sees patients in the electrophysiology clinic on Shapiro 7, implants pacemakers and defibrillators, and performs ablations as well as electrophysiology studies.
Dr. Francine K. Welty is an Associate Professor of Medicine at Harvard Medical School and Principal Investigator and Director of the NHLBI Specialized Center of Clinically Oriented Research in Vascular Injury, Repair and Remodeling. Dr. Welty is principal investigator of the Kuwait Healthy Life Study which examined 8,139 Kuwaiti children at baseline in 2012 with a 2-year follow-up in 2014. With a clinical focus on lipid disorders, preventive cardiology and heart disease in women, she was recently appointed Chair of the Clinical Lipid Committee of the National American Heart Association.
Dr. Meghan York is an Instructor of Medicine at Harvard Medical School and joined the Cardiovascular Institute in 2011. She attends on the general cardiology inpatient and consult services at BIDMC and maintains an active general cardiology practice at Beth Israel Deaconess – Needham Hospital.
CVI Affiliated Physicians at Harvard Vanguard Medical Associates
Interventional Cardiology/Catheterization Laboratory
Dr. Mandeep S. Dhadly is the Chief of the Cardiology Department at Harvard Vanguard Medical Associates. Specific clinical interests include both diagnostic and interventional cardiac and peripheral vascular procedures.
Dr. Mobeen A. Sheikh is an interventional cardiologist and vascular medicine specialist. His clinical interests include coronary and peripheral vascular procedures and his chief research interest is in peripheral arterial disease.
Dr. Kapil (Bobby) Kumar is a Clinical Instructor in Medicine at Harvard Medical School and a member of the BIDMC Electrophysiology section. He directs the Electrophysiology and Cardiac Device Service at Harvard Vanguard Medical Associates. Dr. Kumar’s research interests include non-invasive sudden cardiac death risk assessment and the evaluation of novel antiarrhythmic drugs
Dr. Jane S. Bae is a Clinical Instructor in Medicine at Harvard Medical School. She focuses on clinical and preventative cardiology, has an interest in vascular imaging and specializes in non-invasive cardiovascular imaging including echocardiography and nuclear imaging.
Dr. Patricia A. Come is an Associate Professor of Medicine at Harvard Medical School for over 25 years. She focuses on clinical cardiology and preventative cardiology and is an echocardiographer.
Dr. Andre Dejam is a non-invasive cardiologist that is interested in heart failure. He directs the heart failure program at Harvard Vanguard. His interests are understanding diuretic resistance and establishing systems approaches for CHF patients to avoid hospital admissions.
Dr. Geoffrey S. Hirsowitz is a Clinical Instructor in Medicine at Harvard Medical School. He focuses on clinical cardiology and preventative cardiology.
Dr. Marshall S. Katz is a Clinical Instructor in Medicine at Harvard Medical School. Dr. Katz is the medical director for the Echo lab at Harvard Vanguard Medical Associates. He specializes in non-invasive cardiology, including nuclear, stress testing, echocardiographic imaging and pacemaker follow-up.
Dr. Steven Lampert is a Clinical Instructor in Medicine at Harvard Medical School. Dr. Lampert was the Chief of the Cardiology Department at Harvard Vanguard Medical Associates from 1996-2010. Dr. Lampert focuses on clinical cardiology and preventative cardiology and is particularly interested in congestive heart failure, arrhythmias, pacemakers and ICDs and lipid management.
Dr. Meredith J. Mulhearn focuses on clinical cardiology and preventative cardiology and specializes in non-invasive cardiology including nuclear imaging and echocardiographic imaging. She has a special interest in cardiac rehabilitation.
Dr. Sanjay Shrivastava is a Clinical Instructor in Medicine at Harvard Medical School. Dr. Shrivastava focuses on clinical cardiology and preventative cardiology and specializes in non-invasive cardiovascular imaging including echocardiography, nuclear cardiology and stress testing. His clinical interest includes application of novel biomarkers in cardiovascular disease.
Dr. Mark B. Stockman is a Clinical Instructor in Medicine at Harvard Medical School. Dr. Stockman was the Chief of the Cardiology Department at Harvard Vanguard Medical Associates from 1985-1995. He focuses on clinical cardiology, preventative cardiology and pacemaker follow-up.